Cytomegalovirus glycoprotein B groups associated with retinitis in AIDS

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 184-187

  Shepp, David H ^a   Match, Mark E ^c   Ashraf, Amar B ^b   Lipson, Steven M ^c   Millan, Colleen ^c   Pergolizzi, Robert ^c  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NASSAU UNIVERSITY MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; RESTRICTION ENDONUCLEASE; VIRULENCE FACTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DNA SEQUENCE; ENZYME ACTIVITY; HUMAN; INFECTION RISK; PRIORITY JOURNAL; RETINITIS; RISK FACTOR; VIREMIA; VIRUS ISOLATION;

EID: 0030017129     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.184     Document Type: Article

References (15)

1. Pertel P, Hirschtick R, Phair J, Chmiel J, Poggensee L, Murphy R. Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus. J Acquir Immune Defic Syndr 1992; 5:1069-74.
2. Shepp DH, Moses JE, Kaplan MH. Seroepidemiology of cytomegalovirus in patients with advanced HIV disease: influence on disease expression and survival. J Acquir Immune Defic Syndr 1996 (in press).
3. Gallant JE, Moore RE, Richman DD, Keruly J, Chaisson RE. Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. J Infect Dis 1992;166:1223-7.
4. Chou S, Dennison KM. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis 1992;166:604-7.
5. Rasmussen L, Resta S, Merigan T. Human cytomegalovirus glycoprotein-receptor interactions. Transplant Proc 1991;23(suppl 3):60-3.
6. Rasmussen L. Immune response to human cytomegalovirus infection. Curr Top Microbiol Immunol 1990;154:221-54.
7. Fries BC, Chou S, Boeckh M, Torok-Storb B. Frequency distribution of cytomegalovirus envelope glycoprotein genotypes in bone marrow transplant recipients. J Infect Dis 1994;164:769-74.
8. Lipson SM, Kaplan MH, Simon JK, Ciamician Z, Tseng LF. Improved detection of cytomegalovirus viremia in AIDS patients using shell vial and indirect immunoperoxidase methodologies. J Med Virol 1993;38: 36-43.
9. Chou S. Comparative analysis of sequence variation in gp116 and gp55 components of glycoprotein B of human cytomegalovirus. Virology 1992;188:388-90.
10. Cranage MP, Kouzarides T, Bankier AT, et al. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia viras. EMBO J 1986; 5:3057-63.
11. Lee LG, Connell CR, Woo SL, et al. DNA sequencing with dye-labeled terminators and T7 DNA polymerase: effect of dyes and dNTPs on incorporation of dye-terminators and probability analysis of termination fragments. Nucleic Acids Res 1992;20:2471-83.
12. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbid Mortal Wkly Rep 1992;41(RR-17):1-19.
13. Rook AH. Interactions of cytomegalovirus with the human immune system. Rev Infect Dis 1988;10(suppl 3):S460-7.
14. Leach CT, Detels R, Hennessey K, et al. A longitudinal study of cytomegalovirus infection in human immunodeficiency virus type 1 - seropositive homosexual men: molecular epidemiology and association with disease progression. J Infect Dis 1994;170:293-8.
15. Spector SA, McKinley G, Drew WL, Stempien MJ. A randomized double-blinded study of the efficacy and safety of oral ganciclovir for the prevention of cytomegaloviras disease in HIV-infected persons [abstract 2]. In: Proceedings of the 2nd National Conference on Human Retroviruses and Related Infections (Washington, DC). Alexandria, VA: Foundation for Retrovirology and Human Health, 1995.